Skip to content

Clinical trials

Terminated Non-alcoholic Fatty Liver Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Terminated Country / region: United States Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20061
20072
20083
20091
20101
20112
20122
20134
20144
20153
20165
20177
20186
20198
20207
20216
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated71

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Novartis Pharmaceuticals4
Alexion Pharmaceuticals, Inc.2
Bristol-Myers Squibb2
Columbia University2
Duke University2
Emory University2
Genfit2
Indiana University2
The Geneva Foundation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease71
Fatty Liver14
Liver Cirrhosis9
Obesity8
Fibrosis7
Liver Diseases6
Diabetes Mellitus, Type 24
Hepatitis C3
Insulin Resistance3
Metabolic Syndrome3

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.